Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background . Atherothrombotic disease, including coronary artery disease (CAD) and peripheral artery disease (PAD), can lead to cardiovascular (CV) events, such as myocardial infarction, stroke, limb ischemia, heart failure, and CV death. Aim . Evaluate the humanistic and economic burden of CAD and PAD and identify unmet needs through a comprehensive literature review. Methods . Relevant search terms were applied across online publication databases. Studies published between January 2010 and August 2017 meeting the inclusion/exclusion criteria were selected; guidelines were also included. Two rounds of screening were applied to select studies of relevance. Results . Worldwide data showed approximately 5–8% prevalence of CAD and 10–20% prevalence of PAD, dependent on the study design, average age, gender, and geographical location. Data from the REACH registry indicated that 18–35% of patients with CAD and 46–68% of patients with PAD had disease in one or more vascular beds. Use of medication to control modifiable CV risk factors was variable by country (lower in France than in Canada); statins and aspirin were the most widely used therapies in patients with chronic disease. Survival rates have improved with medical advancements, but there is an additional need to improve the humanistic burden of disease (i.e., associated disability and quality of life). The economic burden of atherothrombotic disease is high and expected to increase with increased survival and the aging population. Conclusion . CAD and PAD represent a substantial humanistic and economic burden worldwide, highlighting a need for new interventions to reduce the incidence of atherothrombotic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Baseline characteristics and medication use and clinical outcomes in patients with CAD and PAD from the REACH Registries of (a) Canada,a (b) France,b and (c) Germanyc [1, 2]. aPatients enrolled from January to October 2004; mean age 68.4 ± 9.9. bPercentage of patients experiencing at least one CV event (Figure (a): CAD n = 1356, PAD n = 146; Figure (b): CAD n = 2397, PAD n = 882; Figure (c): CAD n = 3328, PAD n = 1303). cPatients enrolled from December 2003 to June 2014; mean age 69.1–71.7 across risk groups. dPatients enrolled from December 2003 to June 2014; mean age 68.0–69.4 across risk groups. ACE, angiotensin-converting enzyme; ASA, acetylsalicylic acid; CAD, coronary artery disease; CV, cardiovascular; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/5e14fc8ebda846379e697620627d3268/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-1.jpg)
![Figure 2 The persistent risk of MACE (a) up to 3 years following an index MI (adapted from Blin et al., 2016) [3] and (b) up to 4.5 years following an index MI stratified by age (<72 years old versus ≥72 years old) and risk category (low versus higha) (adapted from Jernberg et al., 2015) [4]. aHigh-risk patients were predefined as those with ≥1 of the following risk factors prior to index; MI: diabetes mellitus, at least one MI prior to index MI event, CABG (proxy for multi-vessel CAD), PAD, stroke, heart failure, or diagnosis of chronic renal dysfunction. CABG, coronary artery bypass graft; CAD, coronary artery disease; CV, cardiovascular; HR, high risk; LR, low risk; MACE, major adverse cardiovascular events; MI, myocardial infarction; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/ef7f32f05aeb4415a5daae684132145b/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mere presence of PAD significantly increases the risk of having atherosclerotic disease in other vascular beds.”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately, 46% to 68% of patients with PAD also had coronary artery disease (CAD) or cerebrovascular disease.[48][49][50]”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191 · cited 1×
“These conditions are characterized by progressive (CLI) or sudden onset (ALI) of pain at rest or nonhealing ischemic wounds or gangrene [27, 44, 45] and can ultimately lead to a loss of limbs [46].”
Background2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Hay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32130-x · Cited by 2,083 · cited 1×
“of mortality and morbidity worldwide, atherothrombotic disease places a substantial medical and economic burden on society [7, 12].”
Background2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941
Research works printed but not linked: 1
- Gowdak L. H. W. Prevalence of refractory angina in clinical practice Heart and Metabolism 2017 72 9 12 2-s2.0-85018667587
Cited by
Items 301–400 of 482
Dörr, G. (2024) · Die Rehabilitation · doi:10.1055/a-2154-3672 · Cited by 1
“Patienten mit pAVK sind hinsichtlich der Verordnungshäufigkeit von Reha-Maß - nahmen [1] und der Kontrolle der Risikofaktoren im Vergleich zu Patienten mit koronarer Herzerkrankung (KHK) bei Hausärzten schlechter eingestellt [2–4].”
Effectiveness of lower limb arterial angioplasty
Szuciak, A., Talarek, K., Szewczyk, J., Świta, M., Skierkowski, B., Drelichowska, A., Ciszewski, P., Azierski, M., & Pikor, D. (2024) · Quality in Sport · doi:10.12775/qs.2024.36.56801 · Cited by 1
Gabriyelyan, A. V., & Cheveliuk, O. V. (2024) · Ukrainian journal of cardiovascular surgery · doi:10.30702/ujcvs/24.32(04)/gch054-1419 · Cited by 1
Herold, J., Dagkonakis, N., Debus, E. S., Rauch‐Kröhnert, U., Zeymer, U., & Bauersachs, R. M. (2025) · VASA · doi:10.1024/0301-1526/a001174 · Cited by 1
Self-citationGuangdian, S. H. E. N., Longzhu, Z. H. U., Ying, J., Shan, S., Luo, Z., Jiang, D., Wu, J., & Zhu, Y. (2025) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0540 · Cited by 1
Haghighatafshar, M., Shekasteband, B., Firuzyar, T., Etemadi, Z., Farhoudi, F., & Shams, M. (2025) · PubMed Central · doi:10.30476/ijms.2024.101112.3372 · Cited by 1
SURGICAL OUTCOMES FOR STENOTIC-OCCLUSIVE VASCULAR LESIONS IN EXTRACRANIAL AND LOWER LIMB ARTERIES
Bodnar, P., Bedenyuk, A. D., Bodnar, T., Bodnar, L., & Verveha, B. M. (2025) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2025;13(1):14-27 · Cited by 1
Borodzicz-Jażdżyk, S., de Mooij, G. W., den Hartog, A. W., Hofman, M. B. M., & Götte, M. (2025) · Journal of Cardiovascular Magnetic Resonance · doi:10.1016/j.jocmr.2025.101900 · Cited by 1
“Early diagnosis of obstructive CAD enables fast initiation of targeted treatment, improves patient quality of life, facilitates rehabilitation, accelerates fast return to the previous socio-economic environment, and reduces costs for society [5,6].”
Bond, A., Bruno, V. D., Sulaiman, N. S., Johnson, J. L., George, S. J., & Ascione, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104718 · Cited by 1
“Severe atherosclerotic disease leads to myocardial infarction (MI) and limb ischemia/amputation globally [1].”
Erfanifar, A., Jahanian, A., Fathy, M., Abbasi, M., Gachkar, L., & Kalbasi, S. (2025) · International Cardivascular Research Journal · doi:10.5812/icrj-154736 · Cited by 1
Gefäßmedizinische Rehabilitation bei Patienten mit peripher arterieller Verschlusskrankheit (pAVK)
Dörr, G. (2025) · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin · doi:10.1055/a-2520-7961 · Cited by 1
Pu, A., Sim, W., Liem, Y.-K., Lai, Y., Park, B., Lee, K., Park, H., & Ban, K. (2025) · Antioxidants · doi:10.3390/antiox14060671 · Cited by 1
Naples Score: A Novel Predictor of Infrapopliteal Artery Disease Severity and Complexity
Süleymanoğlu, C., Kıdık, A., Paçacı, E., Çetınkaya, Z., Yurt, R., & Keleşoğlu, Ş. (2025) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2025.10.006 · Cited by 1
Kang, Q., Yuan, P., Xie, P., Xiao, W., Dong, L., Guan, Z., & Zhang, K. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13750 · Cited by 1
“…disability with limited activities of daily living (12). atherosclerosis (aS), as the most important etiological and pathological basis of cVds (13), contributes to ~45% of cVd‑associated mortalities and >20 million individuals worldwide succumb to aS each year (14). a large number of existing…”
He, Y., Li, Y., Qin, X.-J., Bi, Z.-H., Li, S., Liu, Y., & Miao, L. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1611709 · Cited by 1
Wang, K., Wei, H., Wang, Q. X., Huang, W., Yang, L., & He, C. (2025) · European journal of medical research · doi:10.1186/s40001-025-03532-0 · Cited by 1
“The financial burden of endovascular therapy is significant for China’s aging population, which is growing at an alarming rate [3, 4].”
Shafrina, A. A., Hakiki, R., Sari, R., Ramadhani, Y. N., & Nauval, I. (2025) · Jurnal Gizi Indonesia (The Indonesian Journal of Nutrition) · doi:10.14710/jgi.14.1.19-35 · Cited by 1
“9,10 In short, the elevation of low-density lipoprotein (LDL) levels contributes to its deposition beneath the endothelium, while inflammatory mediators exacerbate disease progression.”
Sun, H., Wang, G., Hu, M., Zhang, W., Qi, L., & Ji, P. (2026) · Journal of International Medical Research · doi:10.1177/03000605261417089 · Cited by 1
“26,27 Early detection and intervention are essential for improving outcomes, and biomarkers such as NPAR may play a valuable role in supporting early diagnosis and guiding personalized treatment strategies.”
Enhanced Antiplatelet Activity of Nitrated Fatty Acid Extracts from Phaseolus vulgaris L.
Rodríguez, L., Montecino-Garrido, H. L., Lagos, F., Carrasco, B., Palomo, I. F., Ormazabal, P., Trostchansky, A., & Fuentes, E. (2026) · Molecules · doi:10.3390/molecules31030488 · Cited by 1
Tsao, N. L., Abramowitz, S. A., Shakt, G. E., Judy, R., Hilliard, A. T., Damrauer, S. M., Assimes, T. L., Clarke, S. L., Tcheandjieu, C., Levin, M. L., et al. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005266 · Cited by 1
Wei, R., Zhang, H., Zhu, C., Yu, Z., Liu, C., Zhu, Z., Wang, T., Liu, Y., Bian, X., & Liu, K. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100786 · Cited by 1
Zhang, L., Liu, W., Xue, Y., Wang, L., Gong, C., She, Z., & Li, H. (2026) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2026.03 · Cited by 1
Cai, H., & Lin, Y. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-04160-3 · Cited by 1
“IHD continues to exert a substantial burden on individuals and healthcare resources globally [14].”
Sandridge, J. K., Hall, S. C., & Bowlin, G. L. (2026) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.70092 · Cited by 1
Meltem, E., Rakıcı, İ. T., Aric, M., Güneş, S. T., Bozkurt, K., Bektaş, C. T., & Mahmutoğlu, A. S. (2026) · European Journal of Radiology · doi:10.1016/j.ejrad.2026.113023 · Cited by 1
Ma, L., Wu, J., Pu, J., Huang, Y., & Qian, K. (2026) · LabMed discovery. · doi:10.1016/j.lmd.2026.100133 · Cited by 1
Marital Status and Clinical Outcomes in Chronic Limb-Threatening Ischemia
Daly, T., (15416271), M. P. F., Olaonipekun, E., Fatani, L., Hasan, H., Kheirelseid, E. A. H., McHugh, S., Aly, S., Moneley, D. S., & Naughton, P. A. (2026) · Journal of Surgical Research · doi:10.1016/j.jss.2026.07.017 · Cited by 1
Prospects of clinical application of cilostazol for peripheral artery disease
Бурлева, Е. П., & Korelin, S. V. (2020) · Angiology and vascular surgery · doi:10.33529/angiq2020304 · Cited by 1
Association of advanced glycation end‐products levels with vascular events in postmenopausal women
Urano, T., Shiraki, M., Imai, T., Iinuma, N., Kuroda, T., Tanaka, S., & Saito, M. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14218 · Cited by 1
Soetisna, T. W., Nugraha, W. A., Rokim, F. S., Namretta, L., Pradana, M. B. R., & Utama, D. (2022) · The Heart Surgery Forum · doi:10.1532/hsf.4123 · Cited by 1
Shih, P.-K., Chen, J., Lin, M., & Wu, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272068 · Cited by 1
Adik-Pathak, L., Shirodkar, S., & Gupta, A. (2022) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0073 · Cited by 1
Li, Q., Qin, L., & Li, J. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00117.2022 · Cited by 1
Pearson, S. J., Sindall, P., Caldow, E., & TABERNER, P. (2022) · International Angiology · doi:10.23736/s0392-9590.22.04922-7 · Cited by 2
Vasconcelos, M. L. D. N., Oliveira, W. B. D., Santos, B. G. D., Amorim, J. D. S., Castilho, R. F. S. D., Ferreira, E. B., Bento, M. A. D. S., Agiolfi, F. K. D. S., Dantas, M. F., & Dalagnol, M. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n3-223 · Cited by 1
Shahsavari, G., Ahmadpour, F., & Yalameha, B. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101816 · Cited by 1
Is N-methylacetazolamide a possible new therapy against ischemia-reperfusion injury?
Pardo, A. C., Zegarra, L. A. D., Arbeláez, L. F. G., Aiello, E. A., & Mosca, S. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1223132 · Cited by 1
“Ischemic heart disease (IHD) is one of the most frequent causes of heart failure and remains the leading reason of mortality worldwide (Bauersachs et al., 2019).”
BackgroundCorrelation between renal metabolism and cardiovascular disease
Deng, S., & Huang, W. (2023) · Metabolism and Translational Medicine · doi:10.54844/mtm.2023.0351 · Cited by 1
Boukheloua, M., Berrehal, M., Baali, A., Chelghoum, S., & Nibouche, D. (2023) · Open Journal of Pathology · doi:10.4236/ojpathology.2023.134019 · Cited by 1
Hypertension Management in Peripheral Artery Disease: A Mini Review
Kharawala, A., Nagraj, S., Pargaonkar, S., Seo, J., Kokkinidis, D. G., & Altin, S. E. (2023) · Current Hypertension Reviews · doi:10.2174/0115734021267004231122061712 · Cited by 1
(Peripheral artery disease of the legs - the current state)
Spáčil, J., & Svobodová, J. (2024) · Cor et Vasa · doi:10.33678/cor.2023.075 · Cited by 1
Multani, A., Stahl, G., Johnson, K., Goade, S., & Arnce, R. D. (2024) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000109 · Cited by 1
Kuruvila, M., Maddineni, K., Koppula, S. R., Patel, B., Ratnani, T., Reddy, A. S., & Markandu, K. (2024) · Cureus · doi:10.7759/cureus.62741 · Cited by 1
Serum Malondialdehyde (MDA) as Predictor for Severity of Coronary Artery Disease (CAD)
(2024) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2024.360963 · Cited by 1
“Coronary artery disease (CAD) is characterized by an insufficient supply of blood and oxygen to the myocardium due to the occlusion of coronary arteries, leading to a mismatch between oxygen demand and supply [1] .”
BackgroundYuan, R., Lei, Q., Xu, H., & Yun, W. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12457 · Cited by 1
Aslanov, A. D., Kalibatov, R. M., Logvina, O., Batov, A., Apikov, A., Kardanova, L. Y., Kugotov, A. K., Bakov, Z., Baksanokov, Z., Taukenova, L., et al. (2024) · Archives of Pharmacy Practice · doi:10.51847/dfcf6mz3gd · Cited by 1
Vaezzadeh, K., Tayebi, P., Jalali, F., Goudarzi, M. T. H., Jafaripour, I., Ziaie, N., & Bijani, A. (2024) · Vascular · doi:10.1177/17085381241307755 · Cited by 1
Schweiger, L., Raggam, R. B., Tóth, G. G., Jud, P., Avian, A., Nemecz, V., Gütl, K., Brodmann, M., & Gary, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321491 · Cited by 1
CircRNA/lncRNA-miRNA-mRNA network in the blood exosomes of patients with atherosclerosisPreprint
Zhang, W., Zhu, T., Li, L., & Guo, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-496464/v1 · Cited by 1
Vastrad, B. M., & Vastrad, C. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.22.529500 · Cited by 1
Pratap, D. S. R. (2020) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v8i11.42
Khanduri, S., Nagpal, N., Malik, D. S., Khan, N. H., Abbas, D. Z., & Patel, Y. D. (2021) · International Journal of Radiology and Diagnostic Imaging · doi:10.33545/26644436.2021.v4.i2b.206
Combined Analysis of ceRNA Regulatory Network and DNA Methylation in CADPreprint
Zhao, Y., Wang, C., Li, W., Jin, B., Xiang, Y., Liang, B., Zhang, X., Lu, Z., & Zheng, F. (2021) · Research Square · doi:10.21203/rs.3.rs-917459/v1
Ebaid, H. H., El-sehili, A., Rasheed, H., Ammar, H., & Mahrous, M. R. (2021) · Cardiometry · doi:10.18137/cardiometry.2021.20.184189
Mingqiu, W. U., ZHANG, Y., & Changbao, H. U. (2022) · Minerva Surgery · doi:10.23736/s2724-5691.22.09527-2
Correia, E. D. F., Gomes, G. V. A., Zaidan, Y. L., Melo, J. A., Melo, V. S., & do Nascimento, J. W. A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i9.31602
The Role of Serum Apelin Levels in Peripheral Artery Disease
Yümün, G., Gürkan, S., Yılmaz, A., & Güzel, S. (2022) · Indian Journal of Surgery · doi:10.1007/s12262-022-03370-y · Cited by 1
“In a previous study with a large series, concomitant vascular pathologies were detected in 20–70% of patients [12].”
Backgroundปัจจัยที่มีผลต่อการทำงานของเซลล์เยื่อบุหลอดเลือดและหลอดเลือดแดงแข็งในผู้สูงอายุ
เมฆรุ่งเรืองวงศ์, ฐ., สะหลี, ช., รุ่งเรือง, ศ., เจริญลาภ, จ., เมฆรุ่งเรืองวงศ์, ศ., & วชิราศรีศิริกุล, ส. (2022) · Health Science Journal of Thailand · doi:10.55164/hsjt.v4i4.255183
Machine Learning-based Model for Early Prediction of Coronary Artery Disease
Nabeel, A., Yadav, S., & Moharana, A. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.373378
Cardiac Rehabilitation For Coronary Artery Disease Patients- A Literature Review
Ansari, M. F., Mania, N., & Sharma, S. (2023) · SALT Journal of Scientific Research in Healthcare · doi:10.56735/saltjsrh.ms2303010110
Rostami, G., Sadeghi, H., & Sokhanguei, Y. (2023) · Journal of Sports Physiology and Athletic Conditioning · doi:10.52547/jspac.39093.3.7.36
Zheng, N., Zhong, J., Chen, X., Su, J., Liu, C., & Jiang, L. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00574-9
“Fourth, patients with stable arteriosclerotic cardiovascular disease included those with CCS [12] and PAD; however, they are classified as having S-ASCVD.”
ResultInfluentialMedizinische Rehabilitation bei Gefäßerkrankungen
Dörr, G., Marx, M., Prokein, R., Oettler, W., Severin, R., Nechwatal, R., & Meng, K. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61379-5_182-1
Vasconcelos, M. L. D. N., Oliveira, W. B. D., Santos, B. G. D., Amorim, J. D. S., Castilho, R. F. S. D., Ferreira, E. B., Bento, M. A. D. S., Agiolfi, F. K. D. S., Dantas, M. F., & Dalagnol, M. (2023) · Brazilian Journal of Development · doi:10.34117/bjdv9n5-147
Athletic Trainers Knowledge and Practices for Sudden Cardiac Death
McClure, B., Gessel, C. L., & Peppel, B. (2023) · Journal of Sports Medicine and Allied Health Sciences Official Journal of the Ohio Athletic Trainers Association · doi:10.25035/jsmahs.09.01.12
Ficachi-Morales, C. S. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.50.008000
(2023) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2023.309018
“(1) Hospital Mortality: Patient comorbidities and hospital volume are the main determinants of the 0.”
BackgroundInfluentialHossan, M. S., Das, P. K., Das, S., Bhattacharyya, P., Ismail, K. M., Mahmud, I., Nur, S. M., Uddin, M. N., Faroque, A. S. M. O., & Hossain, M. E. (2023) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20232508
Xiong, Z., Ning, W., & Li, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3268913/v1
Nangliya, R. M., Boob, M. A., Phansopkar, P. A., & Somaiya, K. J. (2023) · Medical Science · doi:10.54905/disssi/v27i138/e315ms3131
Khaboushan, A. S., Masoudkabir, F., Jalali, A., Vasheghani‐Farahani, A., Mohammadi, Z., Mard, S. A., Rahimi, Z., Hashemi, F., Malihi, R., Danehchin, L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3322472/v1
Cardiologia Teoria e Prática - Edição X
de Freitas, G. B. L., de Souza, A. R. C., Vieira, E. M. M. D. P. M., & de Almeida, C. C. (2023) · doi:10.59290/978-65-6029-036-5
Jung, J., Seo, Y., Her, S., Lee, J., Lee, K., Yoo, K., Moon, K., Moon, D., Lee, S. N., Jang, W. Y., et al. (2023) · Medicina · doi:10.3390/medicina59101808
A pilot study on the prevalence of peripheral arterial disease in Kigali, Rwanda
Dockery, D. M., Nussenzweig, S. C., Harelimana, J. G., Ahishakiye, E., Allu, S., Licht, A. H., Cunningham, R., Ingabire, E., Josiane, I., Nisingizwe, P., et al. (2023) · International Journal of Surgery Global Health · doi:10.1097/gh9.0000000000000352
“Estimates of the global prevalence range from 120 million to above 230 million people, with up to 73% of that disease burden thought to be from low and middle-income countries (LMICs)([3,4]).”
BackgroundAnalysis of cardiovascular risk factors as predictors for coronary artery disease stenosis severity
Abduh, S., & Rizaldy, R. (2023) · Jurnal Kedokteran Syiah Kuala · doi:10.24815/jks.v23i2.31688
Rostami, G., Sadeghi, H., & Sokhanguei, Y. (2022) · Journal of Sports Physiology and Athletic Conditioning · doi:10.61186/jspac.38782.2.5.34
Cardiovascular Diseases and Adipokines: The Role of Visfatin in Coronary Atherosclerosis
Marinova-Zlatinova, Z., Negreva, M. N., & Chervenkov, T. (2024) · International Journal of Biomedicine · doi:10.21103/article14(1)_ra1 · Cited by 1
Just-DNA-Seq, open-source personal genomics platform: longevity science for everyonePreprint
Anton, K., Olga, B., Alexey, K., Maria, K., Nikolay, U., Alina, F., Sergey, E., Malvina, P., Kim, R., & Robi, T. (2024) · arXiv (Cornell University) · doi:10.48550/arxiv.2403.19087 · Cited by 2
“It is more commonly observed in individuals over the age of 50 (Bauersachs et al., 2019).”
BackgroundToftgård, J., Hedskog, H., Rune, L., Svedenhag, J., & Riva, G. (2024) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12883
“Despite improving survival rates, coronary artery disease (CAD) is still one of the major causes of death in both men and women (Bauersachs et al., 2019; Fihn et al., 2012).”
Touray, M. (2024) · Trends in Telemedicine & E-health · doi:10.31031/tteh.2024.04.000600
Alshammari, M. K., Hussain, K. H., Alshammari, M. R., Alshammari, H., Althagafi, H. S., Bajunaid, H. R., Alanzi, B. A., Alshammari, A. A., Alshammari, A. K., Aljasim, M. A. J., et al. (2024) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.2s.37
“106 A broad range of therapeutic and endovascular treatment options are available for PAD which are effective and safe however many complementary and alternative medicine therapies are also in practice hence the focus of this study was to evaluate the efficacy of various CAM for the management of…”
Chronic limb-threatening arterial occlusive disease: experience in lifesaving
Hurtado‐Ortiz, A., Vergara, M. P. Á., Hernández, E. F. M., Paola-Suárez, D., Licht-Ardila, M., Bermon, A., & Espinel, C. (2024) · Angiología · doi:10.20960/angiologia.00642
Halk Sağlığı Usul ve Üslubu - İkinci Kitap Makro Kapsam
Turaman, C. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3181
Negrebetsky, V. V., Агарков, Н. М., & Шмарова, Д. Р. (2023) · Vrach · doi:10.29296/25877305-2023-11-13
Alshuraim, N. F., Almasad, M. N., Alharbi, S. H., Alnuwmasiu, F. M., Alonazi, F. M., Alwahdani, M. N., & Alshammary, N. S. (2024) · International Journal of Health Sciences · doi:10.53730/ijhs.v8ns1.15061
Prevent III score as a predictor of limb salvage and mortality after aortoiliac revascularization
Romana-Dias, L., Alves, D., Vidoedo, J., Rocha-Neves, J. P., Andrade, J. P., & Pereira-Neves, A. (2024) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2024.26066
“[2] Peripheral artery disease involving aortoiliac vessels can have diverse clinical presentations, ranging from claudication to the most severe chronic limb-threatening ischemia (CLTI), defined as severe rest pain, nonhealing wounds, or tissue loss.”
BackgroundButti, A., Abbas, W. A. K., & Hasan, A. Y. (2024) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.11978
“Atherosclerosis represents the major pathophysiological cause of CAD and ischemic heart disease (Bauersachs et al ., 2019).”
BackgroundRostami, G. R., & Sadeghi, H. (2024) · Scientific Journal of Rehabilitation Medicine · doi:10.32598/sjrm.13.3.2745
Gabriyelyan, A. V., & Cheveliuk, O. V. (2024) · The Ukrainian Journal of Clinical Surgery · doi:10.26779/2786-832x.2024.5.33
Nguyễn, T. P. U., & Guzman, J. S. D. (2024) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.112e.2024.858
Assessing ABO Blood Group Relation with Collateral Coronary Circulation Development Quality
Heydari, A. H., Khosroshahi, V. T., Aslanabadi, N., Separham, A., & Fallahabadi, H. (2024) · Nāmah-ʼi Dāniškadah-ʼi piziškī-i Irān. · doi:10.61186/jambr.32.152.209
Trends in the Development of Bioresorbable Scaffolds
Petsukh, G. R., & Валерьевич, П. А. (2024) · Reviews on advanced materials and technologies · doi:10.17586/2687-0568-2024-6-4-164-170
Davari, M., Fatemi, B., Sadeghipour, P., Kebriaeezadeh, A., Maracy, M. R., Soleymani, F., Naderi, N., & Zartab, S. (2025) · BMJ Open · doi:10.1136/bmjopen-2023-081953
“Lastly, socio-economic information and health literacy data for the patients included in the study were not accessible.”
Daoud, A. G., Abbas, W. A. K., Hasan, A. Y., & Hajleh, M. N. A. (2025) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v25i1.1121
Wang, W., Lü, J., & Yao, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5125329
Zeymer, U., Bauersachs, R. M., Dagkonakis, N., Debus, E. S., Herold, J., Anand, S. S., Fox, K. A. A., Aboyans, V., & Rauch‐Kröhnert, U. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02603-w
Self-citationZarrintan, S., Fuson, O., Jagadeesh, V., Gaffey, A. C., Hicks, C. W., & Malas, M. B. (2025) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2025.02.025
Lin, Y., Hsu, C., Lee, J., Hsu, P., Lee, C.-Y., Chen, C., Chen, P., Wu, H.-P., Su, M., Lee, C., et al. (2025) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001224
Metadata
- Authors
- Bauersachs, R., Zeymer, U., Brière, J.-B., Marre, C., Bowrin, K., & Huelsebeck, M.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Klinikum Ludwigshafen (DE)
- Bayer (Germany) (DE)
- Creativ-Ceutical (France) (FR)
- Bayer (United Kingdom) (GB)
- Corresponding author
- Bauersachs, Rupert
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2019-11-26
- Volume
- 2019
- Pages
- 1-9
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- PMC
- PMC7024142
- OpenAlex
- W2990657953
- Semantic Scholar
- 7306e92becdce616c64c569876ca723660f04cb3
- Cited by
- 449
- References
- 52
- Citations by year
- 2026: 39 · 2025: 80 · 2024: 118 · 2023: 102 · 2022: 64 · 2021: 38 · 2020: 8
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cardiovascular Therapeutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
- Funders
- Bayer AG
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- coronary artery disease, peripheral arterial disease, atherothrombosis, disease burden, economic burden, humanistic burden, prevalence, quality of life, disability, statins, aspirin, cardiovascular risk management, survival rate, population aging, unmet needs
- MeSH terms
- Aged, Coronary Artery Disease, Female, Health Services Needs and Demand, Humans, Male, Prognosis, Risk Factors, Global Health, Incidence, Prevalence, Health Care Costs, Cost of Illness, Peripheral Arterial Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.